Caption Management, LLC Glycomimetics Inc Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.25 - $4.05 $8,321 - $26,960	6,657 New	6,657 $8,000
Q1 2021 May 17, 2021	SELL	$2.89 - $4.22 $79,498 - $116,083	-27,508 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$2.69 - $4.24 $326,813 - $515,126	-121,492 Reduced 81.54%	27,508 $103,000
Q3 2020 Nov 16, 2020	BUY	$3.07 - $5.0 $457,430 - $745,000	149,000 New	149,000 $458,000
Q3 2019 Nov 14, 2019	SELL	$2.8 - $12.85 $30,799 - $141,350	-11,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$10.6 - $13.12 $116,600 - $144,320	11,000 New	11,000 $132,000

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $12.1M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.